Fig. 1 · Structure
Documents & Downloads
Cadralazine
Antihypertensive Agent
Cadralazine is an orally active antihypertensive agent that acts as a peripheral arteriolar vasodilator. By selectively relaxing vascular smooth muscle, it promotes the widening of blood vessels, thereby effectively reducing peripheral resistance and lowering blood pressure. This compound is primarily utilized in hypertension research to explore vascular responsiveness and therapeutic interventions for managing elevated blood pressure.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 64241-34-5 |
| Applications | Antihypertensive Agent |
| Formula | C12H21N5O3 |
| Molecular Weight | 283.33 |
| Synonyms | ISF 2469 |
| SMILES | O=C(NNC1=NN=C(N(CC(C)O)CC)C=C1)OCC |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.